Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06980766 · ClinicalTrials.gov registry record
Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 99
- Enrollment target
NCT06980766: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT06980766 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06980766 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.
Primary Outcome
Noninvasive blood pressure measurement accuracy for the Philips EarlyVue VS30 on the intended population in comparison to the reference sphygmomanometer via same arm sequential method with dual auscultators
Interventions
- DEVICE Non Invasive Blood Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2025-03-31 |
What the finished NCT06980766 record still lists
NCT06980766 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non Invasive Blood Pressure is the first listed.
NCT06980766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06980766 about?
NCT06980766 is a clinical study titled "Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor". The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.
What is the current status of trial NCT06980766?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2025-03-10. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT06980766?
The interventions under investigation include: Non Invasive Blood Pressure (DEVICE).
Who is sponsoring clinical trial NCT06980766?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI